Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Interpretation

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Name Of Patient : MR.

Avinash Dudpuri
Received Date & Time : 26/09/2021 14:50:28
Age : 30 YEARS Gender :Male
Printing Date & Time : 27/09/2021 11:50:24
Ref. By Dr. : Patient ID : 1621259
Ref. By Lab :
Company : PRIVATE DOCTOR
SRF ID 0708301559700

Test Name Value Unit Biological Ref Interval

MOLECULAR*
COVID-19 VIRU S QUAL ITATIVE PCR*
FINAL RESULT OF SARS-CoV2 (COVID19) NEGATIVE
E GENE/N GENE(ABI KITS ONLY)/T NEGATIVE
RUNAT ORF1a/ORF1b/N/N2 GENE NEGATIVE
(FOR SEEGENE CEPHEID)

Interpretation
Result Interpretation
Positive RNA specific to SARS-Co V-2 Detected
Negative RNA specific to SARS-CoV-2 not detected
Inconclusive This could be due to presence of inhibitors in the sample. A repeat sample is
recommended in such cases after 3-5 days. Kindly correlate with duration of. illness

NOTE
1. ICMR Registration number for Covid -19 is UPDGND
2. Covid-19 Test conducted as per kits approved by ICMR / CE-IVD / USFDA
3. Real Time RT-PCR is the gold standard Frontline test for diagnosis of COVID-19.
4. COVID-19 is a Notifiable Disease. Detected positive cases have to follow the MOHFW guidelines of strict home isolation
along with other safety measures. Their presence in social places should be subject to as offensive action. The lab cannot
be held responsible for their any such action.
5. Target genes specific for SARS -CoV-2 included in the assay are : E/N gene, RdRp/ORF1 gene.
6. Confirmatory assay is performed and NOT just The SCREENING one
7. TAT is minimum 6 hrs and maximum 24 hrs varying on the sample collection site.
8. Test integrity check points :Strict cold chain maintained &Internal control gene used
9. Negative result does not rule out the possibility of Covid-19 infection. Presence of inhibitors, mutations & insufficient
RNA specific to SARS-CoV-2 can influence the test result. Kindly correlate the results with clinical findings. A negative
result in a single upper respiratory tract sample does not rule out SARS-CoV-2 infection. Hence in such cases a repeat
sample should be sent. If a subsequent sample is tested positive(DETECTED), it may indicate an infection acquired
subsequently/increase in viral load to detectable limit after the first test. Lower respiratory tract sampl es like Sputum, BAL,
ET aspirate are appropriate samples especially in severe and progressive lung disease.
10. Optimum specimen types and timing for peak viral levels during infections caused by 2019 -nCoV have not been determined. Collection
of multiple specimens (types and time points) from the same patient may be necessary to detect the virus. Note:

DR. NEHA JAIN


MD, DNB, MNAMS
Consultant Microbiologist
..

Page No: 1 of 2
Name Of Patient : MR. Avinash Dudpuri
Received Date & Time : 26/09/2021 14:50:28
Age : 30 YEARS Gender :Male
Printing Date & Time : 27/09/2021 11:50:24
Ref. By Dr. : Patient ID : 1621259
Ref. By Lab :
Company : PRIVATE DOCTOR
SRF ID 0708301559700

Test Name Value Unit Biological Ref Interval

The results relate only to the specimens tested and should be correlated with clinical findings and the duration of illness.
11. Testing of referred clinical specimens was considered on the basis of request / referral received from / through State
Surveillance Officer (SSO) of concerned State Integrated Disease Surveillance Programme (IDSP)/ any other health care
facility affirming requirements of the case definition/s.
12. A positive alternate pathogen does not necessarily rule out either, as little is yet known about the role of coinfections.
13. INDETERMINATE results could be due to various reasons:

Presence of very less viral load


Early or late stages of infection
Intermittent viral shedding
Limitations
False positives are minimized by using NTC &Negative control in each Run assay and by ensuring strict
biosafety &biosecurity measures.
False Negatives are minimized by maintaining RNAse free environment, Internal control amplification and by
advising Sample collection from our trained personnel.
Comment
SARS-CoV-2 is a novel strain of coronavirus that has not been previously identified in humans. It has been declared a pandemic.
Transmission among humans occurs via close contact with an infected individual that produces respiratory droplets. Patients hav e been
shown to undergo acute respiratory distress syndrome, which is defined as cytokine storm. The diagnosis relies on detection of nucleic
acid, IgG/IgM antibodies, and a chest radiograph of the suspected individuals. The genome of SARS -CoV-2 is similar to other
coronaviruses that comprise of ten open reading frames (ORFs). SARS-CoV-

*** End of Report ***

DR. NEHA JAIN


MD, DNB, MNAMS
Consultant Microbiologist
..

Page No: 2 of 2

You might also like